Four decades of discovery at EMBL
2026 Lennart Philipson Award recipient Stephen Cusack reflects on his 46 years at EMBL Grenoble and how his work in and out of the laboratory has shaped structural biology.
EditNews
Every electron counts: most detailed protein structure to date revealed
Researchers have used advanced X-ray crystallography methods to determine the resolution of the archaeal rubredoxin protein at unprecedented resolution.
Edit
We are EMBL: Pierre Chazelas on connecting people to support science
EMBL Grenoble’s new Head of Administration brings industry experience to support an environment where science can thrive
Edit
What I’ve Learned: Christoph Müller
Christoph Müller shared his thoughts on the state of life sciences and structural biology after 35 years as a researcher who has made important contributions to the field.
Edit
Building momentum towards Bulgaria’s full EMBL membership
EMBL Heidelberg welcomed a delegation from Bulgaria to strengthen scientific connections and explore opportunities for deeper collaboration.
Edit
Professor Ada Yonath (1939–2026)
EMBL mourns the loss of Professor Ada Yonath (1939–2026), the Nobel Prize-winning crystallographer. We were proud to be part of her orbit as she conducted some of her pioneering work on the ribosome a…
Edit
Bovine stem cells offer new approach to future cultivated steak research
EMBL Barcelona researchers develop self-organising bovine tissues that contain muscle, nerve, and blood vessel cells.
Edit
We are EMBL: Daniel Santos-Oliván on staying flexible as AI reshapes research
Daniel Santos-Oliván, Computational Scientist in the Torres-Sánchez group at EMBL Barcelona, talks about bringing the tools of theoretical physics to biology and how artificial intelligence is reshapi…
Edit
A viral ‘loose cannon’ enzyme helps phages shut down bacterial defences
Scientists have found how phages, viruses that infect bacteria, effectively set off an explosion of protein modifications inside host cells that helps them evade the bacteria’s immune system.
Edit
Protein degradation rate helps explain why humans develop more slowly than mice
Researchers at EMBL analysed the protein degradation rate of around 4,000 genes. Their findings help explain why human embryonic development is slower than mouse embryonic development.
Edit
Welcome: Athanasios Athanassiadis
EMBL’s new Head of Scientific Instrumentation Workshops discusses how building customised experimental setups can enable exciting new research.
Edit
EMBL participates in two new European Commission-funded widening research initiatives
New ‘teaming’ projects in genomic medicine and wastewater monitoring will serve important research needs in Portugal and Latvia.
Edit
A journey through the microbiome, shaped by growth and support
EMBL alumna Lisa Maier, recipient of the 2026 John Kendrew Award, discusses her scientific achievements, the importance of science engagement, and how she carries on the ‘EMBL spirit’
Edit
A new genetic tool helps researchers uncover the logic of gene regulation
Researchers use synthetic biology approaches to test hundreds of DNA sequences for their effect on regulating gene expression.
Edit
New research shows the Golgi complex is involved in DNA repair control
Researchers have found a new layer of control over DNA repair, one that operates outside the nucleus, at the Golgi complex.
Edit
Understanding tropical forest health from above and below
Satellites can monitor tropical forests from above, but they cannot see the microbes beneath the soil. COMADRE brings these two worlds together to reveal a more complete picture of forest health.
Edit
New software helps researchers decode the cellular architecture of lymphoma
How cancer develops and responds to treatment depends not only on the tumour cells themselves but also on the complex ecosystem of surrounding immune cells, blood vessels, and connective tissue. In B-…
Edit
European Researchers’ Night 2026: A festival of science and curiosity
EMBL and Merck are bringing back the European Researchers’ Night to Heidelberg on 25 September 2026, with hands-on science, lab tours, art, and activities for all ages.
Edit
EMBL spin-off Epitome Therapeutics launches to advance precision epigenome editing
Epitome Therapeutics, a new EMBL spin-off, translates epigenome editing research into precision medicines. Co-founded by EMBL group leader Jamie Hackett, the company builds on pioneering research from…
Edit
Scientists map how the flu virus rewires the human cell from the inside
EMBL Hamburg researchers and their collaborators have gained new insights into how the influenza A virus reprograms cellular machinery by tracking molecular interactions directly inside infected cells…
Edit